188 related articles for article (PubMed ID: 35906352)
21. Levo-tetrahydropalmatine attenuates methamphetamine reward behavior and the accompanying activation of ERK phosphorylation in mice.
Su H; Sun T; Wang X; Du Y; Zhao N; Zhu J; Yan J; Chen T; Yun K
Neurosci Lett; 2020 Jan; 714():134416. PubMed ID: 31398456
[TBL] [Abstract][Full Text] [Related]
22. Alleviation of Methamphetamine Sensitization by Partially Lesioning Dopaminergic Terminals with 6-Hydroxydopamine in Nucleus Accumbens.
Chen SC; Chen H; Yu SJ; Chen YH; Wang Y
Cell Transplant; 2021; 30():9636897211052300. PubMed ID: 34743572
[TBL] [Abstract][Full Text] [Related]
23. [Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization].
Nitta A; Hibi Y; Miyamoto Y; Nabeshima T
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Dec; 45(6):525-9. PubMed ID: 21387608
[TBL] [Abstract][Full Text] [Related]
24. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect.
Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J
Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589
[TBL] [Abstract][Full Text] [Related]
25. Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice.
Zhao N; Chen Y; Zhu J; Wang L; Cao G; Dang Y; Yan C; Wang J; Chen T
Neuroscience; 2014 Jan; 258():101-10. PubMed ID: 24269936
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.
Sim MS; Soga T; Pandy V; Wu YS; Parhar IS; Mohamed Z
Metab Brain Dis; 2017 Dec; 32(6):1767-1783. PubMed ID: 28681200
[TBL] [Abstract][Full Text] [Related]
27. Neuronal activation of nucleus accumbens by local methamphetamine administration induces cognitive impairment through microglial inflammation in mice.
Kusui Y; Izuo N; Tokuhara R; Asano T; Nitta A
J Pharmacol Sci; 2024 Mar; 154(3):127-138. PubMed ID: 38395513
[TBL] [Abstract][Full Text] [Related]
28. Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference.
Arezoomandan R; Moradi M; Attarzadeh-Yazdi G; Tomaz C; Haghparast A
Brain Res Bull; 2016 Jul; 125():106-16. PubMed ID: 27346277
[TBL] [Abstract][Full Text] [Related]
29. Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling.
Wang J; Liang M; Shang Q; Qian H; An R; Liu H; Shao G; Li T; Liu X
CNS Neurosci Ther; 2023 Mar; 29(3):831-841. PubMed ID: 36627756
[TBL] [Abstract][Full Text] [Related]
30. Acupuncture inhibition of methamphetamine-induced behaviors, dopamine release and hyperthermia in the nucleus accumbens: mediation of group II mGluR.
Kim NJ; Ryu Y; Lee BH; Chang S; Fan Y; Gwak YS; Yang CH; Bills KB; Steffensen SC; Koo JS; Jang EY; Kim HY
Addict Biol; 2019 Mar; 24(2):206-217. PubMed ID: 29363229
[TBL] [Abstract][Full Text] [Related]
31. mRNA changes in nucleus accumbens related to methamphetamine addiction in mice.
Zhu L; Li J; Dong N; Guan F; Liu Y; Ma D; Goh EL; Chen T
Sci Rep; 2016 Nov; 6():36993. PubMed ID: 27869204
[TBL] [Abstract][Full Text] [Related]
32. Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence.
Toriumi K; Kondo M; Nagai T; Hashimoto R; Ohi K; Song Z; Tanaka J; Mouri A; Koseki T; Yamamori H; Furukawa-Hibi Y; Mamiya T; Fukushima T; Takeda M; Nitta A; Yamada K; Nabeshima T
Int J Neuropsychopharmacol; 2014 Mar; 17(3):443-53. PubMed ID: 24246274
[TBL] [Abstract][Full Text] [Related]
33. Regulation of miR-128 in the nucleus accumbens affects methamphetamine-induced behavioral sensitization by modulating proteins involved in neuroplasticity.
Li J; Zhu L; Su H; Liu D; Yan Z; Ni T; Wei H; Goh ELK; Chen T
Addict Biol; 2021 Jan; 26(1):e12881. PubMed ID: 32058631
[TBL] [Abstract][Full Text] [Related]
34. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
35. Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core.
Everett N; Baracz S; Cornish J
Pharmacol Biochem Behav; 2019 Aug; 183():64-71. PubMed ID: 31202809
[TBL] [Abstract][Full Text] [Related]
36. The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens.
Jang EY; Yang CH; Hedges DM; Kim SP; Lee JY; Ekins TG; Garcia BT; Kim HY; Nelson AC; Kim NJ; Steffensen SC
Addict Biol; 2017 Sep; 22(5):1304-1315. PubMed ID: 27417190
[TBL] [Abstract][Full Text] [Related]
37. Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents.
Mizoguchi H; Yamada K; Nabeshima T
J Pharmacol Sci; 2008 Jan; 106(1):9-14. PubMed ID: 18198472
[TBL] [Abstract][Full Text] [Related]
38. Differential roles of dopamine D1 and D2 receptor-containing neurons of the nucleus accumbens shell in behavioral sensitization.
Kai N; Nishizawa K; Tsutsui Y; Ueda S; Kobayashi K
J Neurochem; 2015 Dec; 135(6):1232-41. PubMed ID: 26442961
[TBL] [Abstract][Full Text] [Related]
39. The distinct roles of various neurotransmitters in modulating methamphetamine-induced conditioned place preference in relevant brain regions in mice.
Su H; Bai J; Fan Y; Sun T; Du Y; Li Y; Wei Z; Chen T; Guo X; Yun K
Neuroreport; 2022 Feb; 33(3):101-108. PubMed ID: 34966126
[TBL] [Abstract][Full Text] [Related]
40. The potential involvement of miR-204-3p-axon guidance network in methamphetamine-induced locomotor sensitization of mice.
Ni T; Li Y; Wang R; Hu T; Guan F; Zhu L; Han W; Chen T
Neurosci Lett; 2019 Aug; 707():134303. PubMed ID: 31153969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
